Home » Topics » Regulatory

Regulatory
RSS

Mianserin studied for treatment of sexual dysfunction

July 16, 1997

Bigmar submits ANDA for leucovorin

July 15, 1997

Teva receives FDA approval for generic estazolam

July 15, 1997

FDA approves antibacterial generic from Mylan

July 14, 1997

Mylan antianxiety/antipsychotic generic approved by FDA

July 14, 1997

Profile of a new formulation of eperisone hydrochloride

July 14, 1997

Knoll receives FDA approval to market Mavik for new indication

July 14, 1997

Ergo Science's Ergoset enters phase II/III trials in obesity

July 14, 1997

Mylan, Purepac and ESI Lederle report FDA generic approvals

July 14, 1997

Once-daily extended-release venlafaxine evaluated in depression

July 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...